BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2002
View Archived Issues
A novel COX-2 inhibitor may increase the antiproliferative effects of lovastatin in colon cancer
Read More
Somatostatin analogue TT-232 reported to be effective against inflammation and hyperalgesia
Read More
IST-FS-29 effective in murine tumor models, well tolerated after repeated doses
Read More
Resiniferatoxin: safe and effective for neurogenic and idiopathic bladder overactivity
Read More
Wild-type and lamivudine-resistant hepatitis B virus susceptible to MCC-478
Read More
Protein phosphatase-1 suppresses learning and memory and may mediate age-related cognitive decline
Read More
New erythromycin antibiotics in early development at Abbott
Read More
Servier researchers report three series of FTase inhibitors
Read More
Dual PDE3/PDE4 inhibitor attenuates inflammation and bronchoconstriction in ARDS
Read More
CRL-42796 prevents experimental carotid and coronary artery thrombosis
Read More
Use of fruit extracts containing momordin Ic in rheumatoid arthritis
Read More
KW-4490 advances to phase II as a potential asthma therapeutic
Read More
NeuroSearch interim report includes R&D update
Read More
Toagosei reveals newest antifungal agents
Read More
Angiogenesis inhibitors a focus of research at Kinetek
Read More
Schering-Plough presents new MCH antagonists for use in obesity
Read More
Analgesic alpha2-adrenoceptor agonists covered by Ortho-McNeil patent
Read More
Novel sustained-release hydrogel-based formulation of paclitaxel compared to Taxol
Read More
Altocor approved for additional indication
Read More
Amevive application to be reviewed within six months
Read More
Funding for EraGen rapid genetic diagnostic test for cystic fibrosis
Read More
New anticancer product candidate at Ariad
Read More
Cymbalta deemed approvable by FDA
Read More
Seasonale NDA accepted for review
Read More
EMEA grants orphan drug status to APT-070 in kidney transplantation
Read More
Primary efficacy endpoints reached in phase III Raptiva study
Read More
MX-8899 evaluated in new radiation-induced dermatitis trial
Read More